Verotoxin IIA Antibodies

Santa Cruz Biotechnology offers a broad range of Verotoxin IIA monoclonal antibodies for research focused on understanding this potent toxin. Verotoxin IIA Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Verotoxin IIA, produced by certain strains of Escherichia coli, inhibits protein synthesis in eukaryotic cells, leading to cell death. The toxin significantly influences the pathogenesis of gastrointestinal diseases and is associated with severe complications such as hemolytic uremic syndrome. Understanding Verotoxin IIA mechanisms is crucial for developing therapeutic strategies and diagnostic tools. Research into Verotoxin IIA cellular interactions continues to reveal new insights about its role in disease progression. Investigating the molecular pathways affected by Verotoxin IIA helps advance our knowledge of bacterial toxin mechanisms. Current studies focus on identifying potential therapeutic targets and developing improved detection methods. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Verotoxin IIA and its impact on human health.